“…In search of new anticancer agents, structural modifications of the alkaloid Luotonin A (first isolated in 1997 [ 1 ]) have found considerable interest during the past two decades [ 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 ]. Like its more prominent (and more potent) naturally occurring relative, Camptothecin (CPT) [ 13 , 14 , 15 ], Luotonin A can act as a topoisomerase 1 poison by stabilizing the DNA/Topo1 complex [ 2 , 16 ].…”